Serum cystatin C as a marker of the renal function

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 58, Issue 7, 1998, Pages 585-592

  Randers, Else ^a,b   Kristensen, J H ^a   Erlandsen, E J ^b   Danielsen, H ^a  

^a Department of Internal Medicine ^*  (Denmark)

^b VIBORG HOSPITAL   (Denmark)

Author keywords

Creatinine; Cysteine proteinase inhibitors; Glomerular filtration rate; Immunoassay; Kidney function tests

Indexed keywords

CREATININE; CYSTATIN C;

ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; DIALYSIS; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; PRIORITY JOURNAL; TURBIDIMETRY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CREATININE; CYSTATINS; CYSTEINE PROTEINASE INHIBITORS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RADIOPHARMACEUTICALS; RENAL DIALYSIS; TECHNETIUM TC 99M PENTETATE;

GLOMERULUS;

EID: 0032414440     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365519850186210     Document Type: Article

References (31)

1. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38: 1933-53.
2. Swan SK. The search continues - an ideal marker of GFR. Clin Chem 1997; 43: 913-4.
3. Olafsson I. The human cystatin C gene promoter: functional analysis and identification of heterogeneous mRNA. Scand J Clin Lab Invest 1995; 55: 597-607.
4. Grubb A, Löfberg H. Human γ-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. Proc Natl Acad Sci USA 1982; 79: 3024-7.
5. Abrahamson M, Olafsson I, Palsdottir A, Ulvsbäck M, Lundwall Å, Jensson O, el al. Structure and expression of the human cystatin C gene. Biochem J 1990; 268: 287-94.
6. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 1992; 38 Supp. 1: 20-7.
7. Tenstad O, Roald AB, Grubb A, Aukland K. Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest 1996; 56: 409-14.
8. Nilsson-Ehle P, Grubb A. New markers for the determination of GFR: iohexol clearance and cystatin C serum concentration. Kidney Int 1994; 46 Supp. 47: 17-9.
9. Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindström V, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994; 40: 1921-6.
10. Pergande M, Jung K. Sandwich enzyme immunoassay of cystatin C in serum with commercially available antibodies. Clin Chem 1993; 39: 1885-90.
11. Finney H, Newman DJ, Gruber W, Merle P, Price CP. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 1997; 43: 1016-22.
12. Filler G, Will I, Priem F, Ehrich JHH, Jung K. Are cystatin C and β2-microglobulin better markers than serum creatinine for prediction of a normal glomerular filtration rate in pediatric subjects? Clin Chem 1997; 43: 1077-8.
13. Löfberg H, Grubb AO. Quantitation of γ-trace in human biological fluids: indications for production in the central nervous system. Scand J Clin Lab Invest 1979; 39: 619-26.
14. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995; 47: 312-8.
15. Collé A, Tavera C, Prévot D, Leung-Tack J, Thomas Y, Manuel Y, et al. Cystatin C levels in sera of patients with human immunodeficiency virus infection. J Immunoassay 1992; 13: 47-60.
16. Ishiguro H, Ohkubo I, Mizokami M, Titani K, Sasaki M. The use of monoclonal antibodies to define levels of cystatin C in normal human serum. Hybridoma 1989; 8: 303-13.
17. Olafsson I, Löfberg H, Abrahamson M, Grubb A. Production, characterization and use of monoclonal antibodies against the major extracellular human cysteine proteinase inhibitors cystatin C and kininogen. Scand J Clin Lab Invest 1988; 48: 573-82.
18. 99mTc-DTPA clearance by a single plasma sample method. Clin Physiol 1986; 6: 579-88.
19. Zweig MH, Campbell G, Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-77.
20. Weher JA, van Zanten AP. Interferences in current methods for measurements of creatinine. Clin Chem 1991; 37: 695-700.
21. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985; 28: 830-8.
22. Mitch WE, Walser M. Nutritional therapy for the uremic patient. In: Brenner BM, editor. The kidney, 5th ed. Philadelphia: W. B. Saunders, 1996; 2382-423.
23. Giovanetti S, Barsotti G. In defense of creatinine clearance. Nephron 1991; 59: 11-4.
24. Narayanan S, Appleton HD. Creatinine: a review. Clin Chem 1980; 26: 1119-26.
25. 131 labelled sodium iothalamate in man. Invest Urol 1965; 2: 432-8.
26. Dubovsky EV, Russell CD. Quantitation of renal function with glomerular and tubular agents. Semin Nucl Med 1982; 12: 308-29.
27. Rehling M, Rabøl A. Measurement of glomerular filtration rate in adults: accuracy of five single-sample plasma clearance methods. Clin Physiol 1989; 9: 171-82.
28. Tian S, Kusano E, Ohara T, Tabei K, Itoh Y, Kawai T, et al. Cystatin C measurement and its practical use in patients with various renal diseases. Clin Nephrol 1997; 48: 104-8.
29. Erlandsen EJ, Randers E, Kristensen JH. Reference intervals for serum cystatin C and serum creatinine in adults. Clin Chem Lab Med 1998; 36: 393-7.
30. 2 microglobulin/cystatin C-ratio. Scand J Clin Lab Invest 1997; 57: 463-70.
31. Bjarnadottir M, Grubb A, Olafsson I. Promoter-mediated, dexamethasone-induced increase in cystatin C production by Hela cells. Scand J Clin Lab Invest 1995; 55: 617-23.